149 related articles for article (PubMed ID: 3383207)
21. Incidence of serum antibody reactivity to autologous head and neck cancer cell lines and augmentation of antibody reactivity following acid dissociation and ultrafiltration.
Vlock DR; Scalise D; Schwartz DR; Richter DE; Krause CJ; Baker SR; Carey TE
Cancer Res; 1989 Mar; 49(6):1361-5. PubMed ID: 2924293
[TBL] [Abstract][Full Text] [Related]
22. Hybridoma antibodies reactive with human bladder carcinoma cell surface antigens.
Grossman HB
J Urol; 1983 Sep; 130(3):610-4. PubMed ID: 6887389
[TBL] [Abstract][Full Text] [Related]
23. Production of a monoclonal antibody selective to human transitional cell carcinoma.
Takahashi N; Koizumi Y; Kawaguchi T; Takahashi K; Suzuki T; Funyu T
Tohoku J Exp Med; 1987 Feb; 151(2):213-20. PubMed ID: 3554615
[TBL] [Abstract][Full Text] [Related]
24. Human transitional cell carcinoma in the NMRI-nu/nu mouse bladder: a new animal model for the in vivo use of monoclonal antibodies and cytotoxic agents.
Huland E; Arndt R; Huland H
Cancer Res; 1986 May; 46(5):2488-9. PubMed ID: 3697989
[TBL] [Abstract][Full Text] [Related]
25. Altered reactivity for A, B, H antigens in transitional cell carcinomas of the urinary bladder. A study of the mechanisms involved.
Limas C; Lange P
Cancer; 1980 Sep; 46(6):1366-73. PubMed ID: 7417937
[TBL] [Abstract][Full Text] [Related]
26. Human bladder cancer associated antigens: evaluation of antigenicity in TCC tissues of different grades and in normal urothelium.
Ben-Aïssa H; Paulie S; Gustafsson B; Håkansson L; Lagerkvist M; Gustafson H; Ahlstrand C; Perlmann P
Anticancer Res; 1988; 8(3):443-9. PubMed ID: 3389746
[TBL] [Abstract][Full Text] [Related]
27. [Immunological detection of an antigen associated with human bladder carcinoma cell lines].
Tsukahara K
Nihon Hinyokika Gakkai Zasshi; 1982 Oct; 73(10):1249-58. PubMed ID: 7166918
[No Abstract] [Full Text] [Related]
28. Monoclonal antibodies raised against cell membrane components of human bladder tumor tissue recognizing subpopulations in normal urothelium.
Summerhayes IC; McIlhinney RA; Ponder BA; Shearer RJ; Pocock RD
J Natl Cancer Inst; 1985 Dec; 75(6):1025-38. PubMed ID: 2415743
[TBL] [Abstract][Full Text] [Related]
29. Immune reactions in patients with superficial bladder cancer after intradermal and intravesical treatment with bacillus Calmette-Guérin.
van der Meijden AP; Steerenberg PA; van Hoogstraaten IM; Kerckhaert JA; Schreinemachers LM; Harthoorn-Lasthuizen EJ; Hagenaars AM; de Jong WH; Debruijne FM; Ruitenberg EJ
Cancer Immunol Immunother; 1989; 28(4):287-95. PubMed ID: 2784716
[TBL] [Abstract][Full Text] [Related]
30. In vitro production of human antibodies specifically reactive with human gastric cancer cells of established lines and autologous tissues.
Takayama T; Sakabe T; Fujii M; Yamada E; Uno M; Ono Y
J Surg Oncol; 1987 Nov; 36(3):215-24. PubMed ID: 2824934
[TBL] [Abstract][Full Text] [Related]
31. A monoclonal antibody to human transitional cell carcinoma of the bladder: production and characterization.
Takahashi N; Takahashi S; Takahashi K; Suzuki T; Funyu T
J Urol; 1987 Jul; 138(1):207-11. PubMed ID: 2439711
[TBL] [Abstract][Full Text] [Related]
32. Expression of a cell surface antigen recognized by the monoclonal antibody AUA1 in bladder carcinoma: an immunohistochemical study.
Zorzos J; Zizi A; Bakiras A; Pectasidis D; Skarlos DV; Zorzos H; Elemenoglou J; Likourinas M
Eur Urol; 1995; 28(3):251-4. PubMed ID: 8536781
[TBL] [Abstract][Full Text] [Related]
33. Human bladder cancer cell-surface antigens recognized by murine monoclonal antibodies raised against T24 bladder cancer cells.
Masuko T; Abe J; Yagita H; Hashimoto Y
Jpn J Cancer Res; 1985 May; 76(5):386-94. PubMed ID: 3924712
[TBL] [Abstract][Full Text] [Related]
34. Monoclonal antibodies against human urinary bladder carcinomas: selectivity and utilization for gamma scintigraphy.
Bubeńik J; Kieler J; Perlmann P; Paulie S; Koho H; Christensen B; Dienstbier Z; Koprivová H; Pospísil J; Poucková P
Eur J Cancer Clin Oncol; 1985 Jun; 21(6):701-10. PubMed ID: 3894033
[TBL] [Abstract][Full Text] [Related]
35. Tumor-associated and spontaneous lymphocyte-mediated cytotoxicity against cell lines derived from human urothelium.
Vilien M
Dan Med Bull; 1985 Aug; 32(4):199-218. PubMed ID: 3899526
[No Abstract] [Full Text] [Related]
36. Monoclonal antibody Due ABC 3 directed against transitional cell carcinoma. I. Production, specificity analysis, and preliminary characterization of the antigen.
Decken K; Schmitz-Dräger BJ; Rohde D; Nakamura S; Ebert T; Ackermann R
J Urol; 1992 Jan; 147(1):235-41. PubMed ID: 1729539
[TBL] [Abstract][Full Text] [Related]
37. Comparison of 15 monoclonal antibodies against tumor-associated antigens of transitional cell carcinoma of the human bladder.
Huland E; Huland H; Meier T; Baricordi O; Fradet Y; Grossman HB; Hodges GM; Messing EM; Schmitz-Draeger BJ
J Urol; 1991 Dec; 146(6):1631-6. PubMed ID: 1719252
[TBL] [Abstract][Full Text] [Related]
38. Monoclonal antibodies against cell surface antigens present on human urinary bladder cancer cells.
Masuko T; Yagita H; Hashimoto Y
J Natl Cancer Inst; 1984 Mar; 72(3):523-30. PubMed ID: 6583438
[TBL] [Abstract][Full Text] [Related]
39. Cell-mediated tumour immunity in patients with transitional cell carcinoma of the urinary bladder.
Bubeník J
Int Urol Nephrol; 1975; 7(4):297-302. PubMed ID: 1107249
[TBL] [Abstract][Full Text] [Related]
40. Natural antibody to a human bladder carcinoma cell line.
Grossman HB
Cancer Immunol Immunother; 1982; 13(2):89-92. PubMed ID: 7159876
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
